PEOPLE - changes at IDMoS:
This article was originally published in Clinica
UK-listed disease detection and monitoring technology specialist IDMoS has appointed non-executive chairman John Pool to interim executive chairman, following CEO Stephen Westwood's decision to leave with immediate effect to pursue other business interests. The board intends to appoint Johnson & Johnson veteran Graham Lay as COO as of mid-July. A new CEO will be appointed "as soon as practical", said the Dundee company.
You may also be interested in...
Europe's largest online pharmacy is calling for online sales of OTC medicines to be allowed in its home market Switzerland, to increase the supply of crucial products to help people manage the symptoms of COVID-19, such as headaches, fever, diarrhoea, coughs, colds or nausea.
Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.
Novartis's Jakavi joins the likes of Roche's Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients.